A citation-based method for searching scientific literature

I Esteban, M Vilaró, E Adrover, A Angulo, E Carrasco, N Gadea, A Sánchez, T Ocaña, G Llort, R Jover, J Cubiella, S Servitja, M Herráiz, L Cid, S Martínez, M J Oruezábal-Moreno, I Garau, S Khorrami, A Herreros-de-Tejada, R Morales, J M Cano, R Serrano, M H López-Ceballos, S González-Santiago, M J Juan-Fita, C Alonso-Cerezo, A Casas, B Graña, A Teulé, E Alba, A Antón, C Guillén-Ponce, A B Sánchez-Heras, J E Alés-Martínez, J Brunet, F Balaguer, J Balmaña. Psychooncology 2018
Times Cited: 17







List of co-cited articles
86 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
62
58

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
43
52

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
169
41

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
30
35

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
162
29

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
157
29

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
53
29

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
501
23


Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
23

Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
W Eijzenga, E M A Bleiker, D E E Hahn, I Kluijt, G N Sidharta, C Gundy, N K Aaronson. Psychooncology 2014
24
23

Uncertainty related to multigene panel testing for cancer: a qualitative study on counsellors' and counselees' views.
Niki M Medendorp, Marij A Hillen, Laxsini Murugesu, Cora M Aalfs, Anne M Stiggelbout, Ellen M A Smets. J Community Genet 2019
12
33

A taxonomy of medical uncertainties in clinical genome sequencing.
Paul K J Han, Kendall L Umstead, Barbara A Bernhardt, Robert C Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B Waterston, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2017
53
23

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
288
17

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
557
17

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
308
17

Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Amy Taylor, Angela F Brady, Ian M Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side. J Med Genet 2018
45
17

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
204
17

Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
Chris Jacobs, Christine Patch, Susan Michie. Eur J Hum Genet 2019
18
17

Cancer risk assessment using genetic panel testing: considerations for clinical application.
Susan Hiraki, Erica S Rinella, Freya Schnabel, Ruth Oratz, Harry Ostrer. J Genet Couns 2014
27
17

Unmet support needs and distress among women with a BRCA1/2 mutation.
Ashley Farrelly, Victoria White, Bettina Meiser, Michael Jefford, Mary-Anne Young, Sandra Ieropoli, Ingrid Winship, Jessica Duffy. Fam Cancer 2013
17
17

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
82
17

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
17

Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.
Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco. J Genet Couns 2014
45
17

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes.
I Pellegrini, M Rapti, J-M Extra, A Petri-Cal, T Apostolidis, J-M Ferrero, T Bachelot, P Viens, C Julian-Reynier, F Bertucci. Eur J Cancer Care (Engl) 2012
21
17

Uncertainty and psychological adjustment in patients with lung cancer.
Keiko Kurita, Edward B Garon, Annette L Stanton, Beth E Meyerowitz. Psychooncology 2013
51
17

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
Mark N Levine, Jim A Julian, Philippe L Bedard, Andrea Eisen, Maureen E Trudeau, Brian Higgins, Louise Bordeleau, Kathleen I Pritchard. J Clin Oncol 2016
57
17

PUGS: A novel scale to assess perceptions of uncertainties in genome sequencing.
B B Biesecker, S W Woolford, W M P Klein, K B Brothers, K L Umstead, K L Lewis, L G Biesecker, P K J Han. Clin Genet 2017
21
17

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.
Kara-Grace Leventhal, William Tuong, Beth N Peshkin, Yasmin Salehizadeh, Mary B Fishman, Susan Eggly, Kevin FitzGerald, Marc D Schwartz, Kristi D Graves. J Genet Couns 2013
25
17


A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.
S Holt, G Bertelli, I Humphreys, W Valentine, S Durrani, D Pudney, M Rolles, M Moe, S Khawaja, Y Sharaiha,[...]. Br J Cancer 2013
73
17

Uncertainty in illness.
M H Mishel. Image J Nurs Sch 1988
566
17

Known unknowns: building an ethics of uncertainty into genomic medicine.
Ainsley J Newson, Samantha J Leonard, Alison Hall, Clara L Gaff. BMC Med Genomics 2016
45
17

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
107
17

Patient experience of uncertainty in cancer genomics: a systematic review.
Nicci Bartley, Christine Napier, Megan Best, Phyllis Butow. Genet Med 2020
6
50

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
212
11

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.
Huma Q Rana, Rebecca Gelman, Holly LaDuca, Rachel McFarland, Emily Dalton, Jennifer Thompson, Virginia Speare, Jill S Dolinsky, Elizabeth C Chao, Judy E Garber. J Natl Cancer Inst 2018
37
11

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
180
11

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
70
11

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
G Llort, I Chirivella, R Morales, R Serrano, A Beatriz Sanchez, A Teulé, E Lastra, J Brunet, J Balmaña, B Graña. Clin Transl Oncol 2015
47
11


Observed frequency and challenges of variant reclassification in a hereditary cancer clinic.
Sarah Macklin, Nisha Durand, Paldeep Atwal, Stephanie Hines. Genet Med 2018
42
11

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, Michael F Walsh, Vijai Joseph, Zsofia K Stadler, Katherine L Nathanson, Judy E Garber, Fergus J Couch, Kenneth Offit,[...]. J Clin Oncol 2016
101
11

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
88
11

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing.
Jada G Hamilton, Jessica M Long, Amanda C Brandt, Jamie Brower, Heather Symecko, Erin E Salo-Mullen, Stephanie N Christian, Tricia Harstad, Fergus J Couch, Judy E Garber,[...]. JCO Precis Oncol 2019
10
20

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146
11

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
308
11



Physicians' reactions to uncertainty in the context of shared decision making.
Mary C Politi, France Légaré. Patient Educ Couns 2010
44
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.